News
8h
Zacks Investment Research on MSNBioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 ViewBioMarin Pharmaceutical BMRN reported second-quarter 2025 adjusted earnings per share (EPS) of $1.44, which beat the Zacks ...
10h
Capital Market on MSNPrakash Industries Ltd leads gainers in 'A' groupNewgen Software Technologies Ltd, Godfrey Phillips India Ltd, Sanofi Consumer Healthcare India Ltd and New India Assurance ...
Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient ...
Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and ...
Converging evidence supports a key pathogenic role of the glymphatic system in the accumulation of pathological aggregates in ...
Sanofi Consumer Healthcare said its growth was driven by successful product launches and the successful relaunch of two ...
Sanofi Consumer Healthcare India surged 12.56% to Rs 5385 after the company announced strong financial results for the second quarter of 2025.
Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results